Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Infections × Probiotics × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 5 Breast Neoplasms 4 Stomach Neoplasms 3 Neoplasms 2 Mucositis 2 Malnutrition 2 Lung Neoplasms 2 Diarrhea 2 Chalazion 2 Carcinoma, Hepatocellular 2 Thyroid Neoplasms 1 Squamous Intraepithelial Lesions 1 Smoldering Multiple Myeloma 1 Psychological Well-Being 1 Polycystic Ovary Syndrome 1 Periampullary Carcinoma Nos 1 Pelvic Neoplasms 1 Papillomavirus Infections 1 Ovarian Neoplasms 1 Neoplasms, Second Primary 1 Muscle Invasive Bladder Cancer (MIBC) 1 Multiple Myeloma 1 Motor Activity 1 Monoclonal Gammopathy of Undetermined Significance 1 Liver Cirrhosis 1 Limited Stage Small Cell Lung Cancer 1 Laryngeal Neoplasms 1 Infections 1 Helicobacter Infections 1 Generalized Anxiety Disorder 1

Interventions

Trimethoprim, Sulfamethoxazole Drug Combination 8 Ciprofloxacin 6 Fluconazole 3 Daptomycin 3 Antibiotic Prophylaxis 3 gamma-Globulins 2 Voriconazole 2 Vancomycin 2 Trimethoprim 2 Sulfamethoxazole 2 Saline Solution 2 Ribavirin 2 Peripheral Blood Stem Cell Transplantation 2 Pentetic Acid 2 Melphalan 2 Itraconazole 2 Immunoglobulins, Intravenous 2 Fosfomycin 2 Ethanol 2 Cyclophosphamide 2 Cefazolin 2 Amoxicillin-Potassium Clavulanate Combination 2 ziprasidone 1 tocilizumab 1 telavancin 1 telaprevir 1 talquetamab 1 soybean oil, phospholipid emulsion 1 peginterferon alfa-2a 1 monalizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03785938 2018-12-24

MaCROS

University of Leeds

Phase NA Unknown

Infections, Neoplasms, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡